Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0MH6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,366
Award facts
- Contract value 100% obligated
- $35,366.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,366.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. This non-set-aside contract is scheduled for completion by January 28, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. This larger contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the delivery of a broad range of prescription medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that supplies critical medical commodities to federal agencies including the Defense Health Agency, U.S. Coast Guard, and military treatment facilities. The company's federal contracting history demonstrates consistent capability to competitively deliver pharmaceutical products across multiple therapeutic domains through firm fixed-price arrangements. This delivery order for Dupixent, a biologic immunosuppressant medication, exemplifies the contractor's role in supplying specialty medications essential to military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0MH6?
SPE2DR26F0MH6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F0MH6 worth?
The government has obligated $35,366 on SPE2DR26F0MH6.
Is contract SPE2DR26F0MH6 an order under another contract?
Yes. SPE2DR26F0MH6 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0MH6 competed?
The extent of competition for SPE2DR26F0MH6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award